Swiss National Bank’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.85M | Hold |
166,483
| – | – | ﹤0.01% | 1598 |
|
|
2025
Q1 | $10.6M | Sell |
166,483
-2,300
| -1% | -$147K | 0.01% | 864 |
|
|
2024
Q4 | $20.5M | Buy |
168,783
+2,700
| +2% | +$328K | 0.01% | 630 |
|
|
2024
Q3 | $20.7M | Hold |
166,083
| – | – | 0.01% | 635 |
|
|
2024
Q2 | $26.2M | Sell |
166,083
-100
| -0.1% | -$15.8K | 0.02% | 560 |
|
|
2024
Q1 | $21.5M | Buy |
166,183
+9,900
| +6% | +$1.28M | 0.02% | 626 |
|
|
2023
Q4 | $15.1M | Sell |
156,283
-17,800
| -10% | -$1.72M | 0.01% | 698 |
|
|
2023
Q3 | $21.1M | Buy |
174,083
+11,300
| +7% | +$1.37M | 0.02% | 615 |
|
|
2023
Q2 | $18.6M | Sell |
162,783
-7,717
| -5% | -$884K | 0.01% | 659 |
|
|
2023
Q1 | $23.5M | Sell |
170,500
-19,800
| -10% | -$2.73M | 0.02% | 605 |
|
|
2022
Q4 | $24.7M | Sell |
190,300
-6,800
| -3% | -$881K | 0.02% | 593 |
|
|
2022
Q3 | $21.8M | Buy |
197,100
+2,200
| +1% | +$243K | 0.02% | 614 |
|
|
2022
Q2 | $14.6M | Sell |
194,900
-700
| -0.4% | -$52.5K | 0.01% | 734 |
|
|
2022
Q1 | $15.3M | Buy |
195,600
+28,600
| +17% | +$2.23M | 0.01% | 787 |
|
|
2021
Q4 | $15M | Sell |
167,000
-400
| -0.2% | -$36K | 0.01% | 806 |
|
|
2021
Q3 | $15.5M | Buy |
167,400
+800
| +0.5% | +$74K | 0.01% | 773 |
|
|
2021
Q2 | $13M | Sell |
166,600
-120,573
| -42% | -$9.37M | 0.01% | 887 |
|
|
2021
Q1 | $21.4M | Buy |
287,173
+5,800
| +2% | +$432K | 0.01% | 672 |
|
|
2020
Q4 | $48M | Sell |
281,373
-6,900
| -2% | -$1.18M | 0.03% | 487 |
|
|
2020
Q3 | $40.5M | Sell |
288,273
-4,000
| -1% | -$562K | 0.03% | 474 |
|
|
2020
Q2 | $46.9M | Buy |
292,273
+2,900
| +1% | +$465K | 0.04% | 421 |
|
|
2020
Q1 | $28.3M | Buy |
289,373
+55,000
| +23% | +$5.38M | 0.03% | 475 |
|
|
2019
Q4 | $30.2M | Sell |
234,373
-9,700
| -4% | -$1.25M | 0.03% | 512 |
|
|
2019
Q3 | $18.4M | Buy |
244,073
+118,073
| +94% | +$8.89M | 0.02% | 587 |
|
|
2019
Q2 | $19.1M | Buy |
126,000
+3,900
| +3% | +$593K | 0.02% | 592 |
|
|
2019
Q1 | $14.6M | Buy |
122,100
+10,500
| +9% | +$1.25M | 0.02% | 635 |
|
|
2018
Q4 | $12.2M | Buy |
111,600
+3,000
| +3% | +$327K | 0.02% | 626 |
|
|
2018
Q3 | $17.5M | Buy |
108,600
+2,100
| +2% | +$339K | 0.02% | 602 |
|
|
2018
Q2 | $14.1M | Hold |
106,500
| – | – | 0.02% | 627 |
|
|
2018
Q1 | $7.89M | Buy |
106,500
+2,400
| +2% | +$178K | 0.01% | 808 |
|
|
2017
Q4 | $5.79M | Buy |
104,100
+4,700
| +5% | +$262K | 0.01% | 955 |
|
|
2017
Q3 | $4.51M | Buy |
99,400
+14,000
| +16% | +$635K | 0.01% | 1083 |
|
|
2017
Q2 | $2.88M | Hold |
85,400
| – | – | ﹤0.01% | 1349 |
|
|
2017
Q1 | $2.53M | Buy |
85,400
+3,200
| +4% | +$94.7K | ﹤0.01% | 1424 |
|
|
2016
Q4 | $2.26M | Hold |
82,200
| – | – | ﹤0.01% | 1473 |
|
|
2016
Q3 | $5.05M | Buy |
82,200
+5,100
| +7% | +$313K | 0.01% | 905 |
|
|
2016
Q2 | $1.47M | Buy |
77,100
+2,400
| +3% | +$45.8K | ﹤0.01% | 1723 |
|
|
2016
Q1 | $1.41M | Buy |
74,700
+13,000
| +21% | +$246K | ﹤0.01% | 1677 |
|
|
2015
Q4 | $2.38M | Buy |
61,700
+3,400
| +6% | +$131K | 0.01% | 1212 |
|
|
2015
Q3 | $1.87M | Buy |
58,300
+6,200
| +12% | +$199K | ﹤0.01% | 1362 |
|
|
2015
Q2 | $1.59M | Hold |
52,100
| – | – | ﹤0.01% | 1472 |
|
|
2015
Q1 | $692K | Buy |
52,100
+2,600
| +5% | +$34.5K | ﹤0.01% | 1985 |
|
|
2014
Q4 | $716K | Buy |
49,500
+8,600
| +21% | +$124K | ﹤0.01% | 1939 |
|
|
2014
Q3 | $863K | Hold |
40,900
| – | – | ﹤0.01% | 1753 |
|
|
2014
Q2 | $1.22M | Buy |
40,900
+2,300
| +6% | +$68.5K | ﹤0.01% | 1602 |
|
|
2014
Q1 | $928K | Buy |
38,600
+11,000
| +40% | +$264K | ﹤0.01% | 1755 |
|
|
2013
Q4 | $562K | Buy |
27,600
+1,100
| +4% | +$22.4K | ﹤0.01% | 1913 |
|
|
2013
Q3 | $1.25M | Sell |
26,500
-1,400
| -5% | -$66.1K | 0.01% | 1285 |
|
|
2013
Q2 | $1.06M | Buy |
+27,900
| New | +$1.06M | ﹤0.01% | 1380 |
|